Cerevance: Funding, Investors & Team (Oct 2026)
Cerevance is a biotech firm that creates new treatments for neurological disorders, specifically focusing on chronic conditions like Alzheimer's, Parkinson's, frontotemporal dementia, and amyotrophic lateral sclerosis. Through analyzing a vast collection of human brain tissue samples, the company gathers extensive expression and epigenetic information, allowing them to pinpoint the most effective targets for future treatments for central nervous system disorders.
Cerevance has raised $183M across 4 funding rounds on record, the most recent a Series C of $20.0M announced in May 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cerevance Company Profile and Key Stats
Latest funding round on record: May 2026.
Cerevance Funding Rounds
Cerevance raised $65.0M in an undisclosed round announced in Apr 2020.
2.8 years later, a Series B of $51.0M was announced in Feb 2023.
1.2 years later, a Series B of $47.0M was announced in Apr 2024.
2.1 years later, a Series C of $20.0M was announced in May 2026.
Cerevance Founders and Leadership Team
Contact details for the Cerevance team: 2 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Cerevance Funding Compared to Other Biotechnology Startups
Cerevance's latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cerevance in Biotechnology and Boston
Companies Similar to Cerevance
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Cerevance Funding FAQs
What does Cerevance do?
Cerevance is a biotech firm that creates new treatments for neurological disorders, specifically focusing on chronic conditions like Alzheimer's, Parkinson's, frontotemporal dementia, and amyotrophic lateral sclerosis. Through analyzing a vast collection of human brain tissue samples, the company gathers extensive expression and epigenetic information, allowing them to pinpoint the most effective targets for future treatments for central nervous system disorders.
How much funding has Cerevance raised?
Cerevance has raised $183M across 4 rounds on record. The most recent is a Series C of $20.0M announced in May 2026.
When did Cerevance last raise funding?
Cerevance's most recent funding round on record is a Series C of $20.0M, announced in May 2026.
Who founded Cerevance?
FundedIQ lists Craig Thompson (Founder), Mark Carlton (Founder) at Cerevance.
Who is the CEO of Cerevance?
Brad Margus is listed as CEO at Cerevance.
Where is Cerevance headquartered?
Cerevance is based in Boston, Massachusetts, United States.
How many employees does Cerevance have?
Cerevance is in the 51-100 employee band.
How does Cerevance's funding compare to other Biotechnology startups?
Cerevance's latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cerevance Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cerevance is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.